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Abstract
Purpose The craniometrics of head circumference (HC) and ventricular size are part of the clinical assessment of infants with
hydrocephalus and are often utilized in conjunction with other clinical and radiological parameters to determine the success of
treatment. We aimed to assess the effect of endoscopic third ventriculostomy (ETV) and shunting on craniometric measurements
during the follow-up of a cohort of infants with symptomatic triventricular hydrocephalus secondary to aqueductal stenosis.
Methods We performed a post hoc analysis of data from the International Infant Hydrocephalus Study (IIHS)—a prospective,
multicenter study of infants (< 24 months old) with hydrocephalus from aqueductal stenosis who were treated with either an ETV
or shunt. During various stages of a 5-year follow-up period, the following craniometrics were measured: HC, HC centile, HC zscore, and frontal-occipital horn ratio (FOR). Data were compared in an analysis of covariance, adjusting for baseline variables
including age at surgery and sex.
Results Of 158 enrolled patients, 115 underwent an ETV, while 43 received a shunt. Both procedures led to improvements in the
mean HC centile position and z-score, a trend which continued until the 5-year assessment point. A similar trend was noted for FOR
which was measured at 12 months and 3 years following initial treatment. Although the values were consistently higher for ETV
compared with shunt, the differences in HC value, centile, and z-score were not significant. ETV was associated with a significantly
higher FOR compared with shunting at 12 months (0.52 vs 0.44; p = 0.002) and 3 years (0.46 vs 0.38; p = 0.03) of follow-up.
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Conclusion ETV and shunting led to improvements in HC centile, z-score, and FOR measurements during long-term follow-up
of infants with hydrocephalus secondary to aqueductal stenosis. Head size did not significantly differ between the treatment
groups during follow-up, however ventricle size was greater in those undergoing ETV when measured at 1 and 3 years following
treatment.
Keywords International Infant Hydrocephalus Study . Infant hydrocephalus . Endoscopic third ventriculostomy . Shunt

Introduction
The pre- and post-operative assessment of infants with hydrocephalus typically includes measurements of head circumference (HC) and ventricular size. Together with other clinical
and radiological parameters, such craniometrics may be helpful in determining the success of treatment. Changes in ventricular size following shunting or endoscopic third
ventriculostomy (ETV) have been studied widely in the pediatric population, with successful shunting able to decrease
ventricular size relatively quickly, while successful ETV also
decreases ventricular size, but less consistently so [1–4]. A
decrease or stabilization of HC z-score is typically expected
following successful treatment [2]. However, despite the ubiquitous practice of measuring HC, the effect of treatment on the
rate of head growth remains an understudied metric, particularly in the infant population.
The International Infant Hydrocephalus Study (IIHS) was a
multicenter prospective study of infants (< 24 months old)
with symptomatic triventricular hydrocephalus from
aqueductal stenosis [5–7]. It is the first prospective study directly comparing the long-term outcomes of shunting and
ETV for infant hydrocephalus. No significant difference in
overall health status and quality of life was observed which
was the primary outcome measure, reported in 2018 [7].
Herein, we present our findings of a post hoc analysis that
examined the effect of shunting and ETV on ventricular size
and HC during follow-up.

gestational age > 36 weeks at birth; pre-operative magnetic resonance imaging (MRI) showing aqueductal stenosis with no other major brain anomalies. Patients with
a history of intraventricular hemorrhage (intra-uterine or
post-natal) or intracranial infection were included, unless
this related to prematurity. Patients with the following
conditions were excluded: open spina bifida; Dandy
Walker syndrome with vermian agenesis/dysgenesis;
perinatal asphyxia; severe brain dysmorphic anatomical
features; known chromosomal abnormalities; or intracranial tumor.
Treatment failure was defined as the need for any repeat
intervention for CSF diversion (including ETV or shunt insertion/revision) determined by the treating surgeon, following
standard clinical practice, or death related to hydrocephalus.
The treating surgeon then decided whether to repeat the primary surgery or try the alternative treatment, essentially
“crossing-over” the patient from their primary treatment.

Craniometrics
Measurements at enrolment and during follow-up were performed in the following manner:
&

Methods
Descriptions of the IIHS have been published previously
[5–7]. Centers experienced in pediatric neuroendoscopy prospectively enrolled infants with hydrocephalus secondary to
aqueductal stenosis that was amenable to treatment with a
ventriculoperitoneal shunt (VPS) or ETV. Initially, the study
included both randomized and non-randomized arms, but
poor recruitment into the randomized arm led to analyses being performed on the combined cohort [8]. Recruitment occurred between 2004 and 2013.
The following inclusion criteria were applied: <
24 months of age at time of operation; symptomatic
triventricular hydrocephalus requiring primary treatment;

&

Head circumference: Measurements performed at the bedside in the standard manner were recorded in centimeters
(cm) to calculate percentile positions and z-scores at several stages of follow-up. The z-scores are an age-corrected
unit describing the HC deviance from the mean value of
the reference population divided by the standard deviation
for the reference population based upon the 2006 WHO
Child Growth Standards (https://www.who.int/
childgrowth/en/). A z-score of − 2, − 1, 1, and 2
approximately correspond to the 2.5th, 15th, 85th, and
9 8 t h c e n t il e s , r e s p e c t i v e l y. T h e z - s c o r e s a r e
advantageous in that they provide a single directional
unit reflecting deviation of HC, facilitating comparisons
at the extremes of distribution.
Ventricular size: MRIs performed pre-operatively and at
12 months and 3 years of follow-up were utilized to calculate the frontal-occipital horn ratio (FOR). FOR is a
validated ratio in pediatric hydrocephalus that has been
demonstrated to have a high degree of inter-observer reliability [9, 10]. The normal ventricle size is 0.37 ± 0.03 [9].
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Analysis
Data collected from the randomized and non-randomized arms
of the study were pooled to compare craniometric measurements for those undergoing ETV versus shunt as their primary
surgery. Descriptive data are presented as mean and standard
deviation (SD) or median and inter-quartile range (IQR) where
appropriate. Comparisons of baseline data to determine potential imbalances in pre-operative measurements were undertaken
using chi-square or Mann-Whitney tests, as appropriate.
An analysis of covariance (ANCOVA) was undertaken
using HC, HC percentile, HC z-score, and FOR as dependent
variables to compare measurements at various stages of
follow-up for infants undergoing ETV or shunt, adjusting for
patient age at first surgery (months), sex, history of infection
or hemorrhage, and geographical continent. An intention to
treat analysis was performed, whereby data collected at each
stage of follow-up was analyzed based on the primary treatment modality. Recognizing that some of these patients will
have crossed-over to the other treatment arm, thus clouding
the interpretation of the data, the analyses were repeated by
limiting the cohort to only those patients who did not experience any treatment failure and, therefore, remained with their
primary treatment modality throughout without crossing-over.
The IIHS was publicly registered (NCT00652470) and received ethics approval from all participating institutions.
Participating investigators and other trial personnel are listed
in the Acknowledgments.

Results
One hundred and fifty eight eligible patients were previously
analyzed, of whom 115 underwent ETV and 43 had a shunt as
Table 1 Baseline characteristics
(adapted from [6]). HC, head
circumference; FOR, frontaloccipital horn ratio, %tile,
percentile

the primary intervention. Patients were enrolled from 27 centers in 4 continents (see [6] for breakdown of centers per
continent). Infants undergoing ETV were slightly older than
shunted patients (4.3 versus 2.2 months, p = 0.007) and had
slightly lower mean HC percentile values (86.3 versus 93.4;
p = 0.03) and z-scores (2.35 versus 3.98; p = 0.02) than
shunted patients, but otherwise the baseline characteristics
were similar (Table 1).
During a median follow-up period of 35 months (IQR 22–
57), 47 patients (29.7%; 38 ETV patients and 9 shunt patients)
failed primary treatment. Among these failures, there was 1
hydrocephalus-related death (in the primary shunt group) due
to presumed shunt failure in a child who died prior to being
transferred to the treating neurosurgical center. The remaining
majority went on to receive a second procedure (ETV or
shunt). Data analysis pertaining to treatment failure has previously been reported [11].
Table 2 illustrates the mean craniometric measurements obtained during follow-up for patients in each treatment cohort.
Both procedures led to reductions in HC percentile, z-scores,
and FOR during the 5-year study period. Head size metrics
were not significantly different between treatment groups at
any assessment point; however, ventricular size (FOR) was
significantly greater in the ETV cohort at 1 (0.52 versus 0.44;
p = 0.002) and 3 years (0.46 versus 0.38; p = 0.03) of follow-up
(Table 2, Figs. 1 and 2). The mean ventricular size of shunted
patients was near normal when measured at 3 years (Fig. 2).
Re-defining the cohort further such that any patient
experiencing treatment failure was excluded from analysis (cohort sizes with complete data at 5 years; ETV,
42, shunt, 13), the findings were similar in that cranial
size metrics did not significantly differ between treatment modalities at the 5-year follow-up point, while
FOR remained greater in the ETV cohort at 12 months

Age in months (median, IQR)
Age categories (number, %)
< 30 days
30 days to < 6 months
6 to < 12 months
12 to < 24 months
Sex (M/F)
History of infection (number, %)
History of hemorrhage (number, %)
Treatment failure (number, %)
Length of follow-up, months (median, IQR)
HC %tile (n = 157) (mean, SD)
z-score (n = 157) (mean, SD)
FOR (n = 148) (mean, SD)

Overall

ETV (n = 115)

Shunt (n = 43)

p value

3.6 (1.6–6.6)

4.3 (1.8–7.7)

2.2 (0.6–5.3)

0.007

29 (18.4%)
83 (52.5%)
28 (17.7%)
18 (11.4%)
100/58
9 (5.7%)
9 (5.7%)
47 (29.7%)
35 (22–57)
88.2 (22.6)
2.8 (2.96)
0.61 (0.09)

15 (13.0%)
60 (52.2%)
24 (20.9%)
16 (13.9%)
74/41
4 (3.5%)
8 (7.0%)
38 (33.0%)
37 (24–56)
86.3 (24.8)
2.35 (2.18)
0.61 (0.08)

14 (32.6%)
23 (53.5%)
4 (9.3%)
2 (4.7%)
26/17
5 (11.6%)
1 (2.3%)
9 (20.9%)
34 (11–59)
93.4 (14.3)
3.98 (4.23)
0.62 (0.12)

0.71
0.06
0.44
0.17
0.36
0.03
0.02
0.33
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Craniometric data measured during follow-up
Adjusted difference between ETV
and shunt (95% confidence interval)*

Adjusted p value*

32
48.6 (3.5)
79.9 (28.5)

− 0.225 (− 1.5 to 1.1)
− 2.925 (− 15.4 to 9.6)

0.73
0.64

2.0 (2.3)
0.52 (0.11)

2.0 (2.4)
0.44 (0.13)

− 0.3 (− 1.3 to 0.6)
0.08 (0.03 to 0.12)

0.49
0.002

86
50.0 (2.8)
81.4 (28.3)
1.84 (2.0)

30
49.1 (2.5)
71.1 (31.5)
1.21 (1.75)

0.6 (− 0.6 to 1.7)
6.4 (− 6.1 to 18.9)
0.41 (− 0.42 to 1.24)

0.32
0.31
0.33

Metric

ETV

Shunt

12 months
N
HC in cm (mean, SD)
HC %tile (mean, SD)

85
48.8 (3.3)
80.1 (31.2)

HC z-score (mean, SD)
FOR (mean, SD)
18 months
N
HC in cm (mean, SD)
HC %tile (mean, SD)
HC z-score (mean, SD)
2 years
N
HC in cm (mean, SD)
HC %tile (mean, SD)
HC z-score (mean, SD)
3 years
N
HC in cm (mean, SD)
HC %tile (mean, SD)
HC z-score (mean, SD)
FOR (mean, SD)

93
50.9 (2.9)
82.4 (27.8)
1.88 (2.0)

28
49.7 (2.6)
71.7 (33.0)
1.14 (1.74)

1.1 (− 0.2 to 2.3)
9.2 (− 3.6 to 22.0)
0.74 (− 0.14 to 1.61)

0.09
0.16
0.10

85
51.5 (3.1)
78.3 (31.6)
1.67 (2.31)
0.46 (0.12)

27
50.4 (2.8)
65.3 (33.9)
0.86 (1.89)
0.38 (0.08)

1.1 (− 0.2 to 2.4)
11.9 (− 2.33 to 26.1)
0.87 (− 0.11 to 1.84)
0.07 (0.01 to 0.13)

0.09
0.10
0.08
0.03

5 years
N
HC in cm (mean, SD)
HC %tile (mean, SD)
HC z-score (mean, SD)

62
52.5 (2.96)
71.3 (31.9)
1.29 (2.19)

17
51.6 (2.02)
64.4 (33.2)
0.62 (1.42)

0.82 (− 0.71 to 2.34)
5.4 (− 12.6 to 23.4)
0.59 (− 0.55 to 1.73)

0.29
0.55
0.30

N, cohort size with complete data; ETV, endoscopic third ventriculostomy; HC, head circumference; FOR, frontal-occipital ratio, %tile, percentile.
*Adjusted p values and adjusted mean differences were derived from ANCOVA models, adjusted for age, sex, history of infection/hemorrhage, and
geographical continent. P values in italics were deemed statistically significant

and 3 years (0.49 versus 0.38; p = 0.002) (Table 3). The
mean HC measurement and z-score value were significantly greater in the ETV group at 2 years of follow-up,
though this difference did not persist at 3 and 5 years
(Table 3).

Discussion
This post hoc analysis of the IIHS cohort of infants with
aqueductal stenosis treated with either ETVor shunt has demonstrated some important findings. First, the data show that
both ETV and shunting led to improvements in HC percentile,
HC z-score, and FOR measurements during long-term followup, including measurements obtained at the 5 year posttreatment stage. Second, cranial size, although numerically
greater for ETV, did not significantly differ between the

treatment cohorts during follow-up; however, ventricular size
remained significantly greater in those undergoing ETV compared with shunted patients when measured at 1 and 3 years
following treatment (Figs. 1 and 2).
The latter observation is in keeping with other studies
where shunting has been more reliable at decreasing ventricular size than ETV [12, 13]. The addition of choroid plexus
cauterization (CPC) to ETV adds the potential of reducing
CSF production; but its true effect and outcomes remain
understudied. Dewan et al. recently compared 6-month
craniometric outcomes in an infant cohort with a range of
pathologies undergoing successful treatment with VPS or
ETV/CPC [14]. Ventricle size (FOR) was also observed to
decrease significantly more following VPS insertion compared with ETV/CPC. Six months following treatments, ventricular size remained unchanged in the ETV/CPC group
while a 27% decrease was observed in the VPS treated group

Childs Nerv Syst (2020) 36:1407–1414
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Distribution of FOR Values
.80

.80

.60

.60

.40

.40

.20

.20

20.0

15.0

10.0

(to near normal). Absolute HC values at 6 months did not
differ between the treatment groups, though the average HC
centile was higher in the ETV/CPC group at 6 months postoperatively (76th vs 54th percentile for ETV/CPC and shunted
patients respectively; p = 0.046). Their study was limited by
its short follow-up period and heterogeneous cohort mix with

5.0

0.0

5.0

10.0

Number of Patients

15.0

FOR 12 mth

FOR 12 mth

Fig. 1 Population pyramid
demonstrating frequency and
distribution of FOR values
measured 12 months following
shunt (black) or ETV (gray).
FOR, frontal-occipital horn ratio

20.0

regard to hydrocephalus etiology. Further work analyzing the
success/failure of ETV/CPC suggests the collective assessment of metrics is necessary and advisable when making treatment decisions [15].
Although taking repeated measurements of HC is a simple
and safe method for monitoring infant head growth, there is a

Distribution of FOR Values
.80
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5.0

0.0

5.0

Number of Patients

10.0

15.0

FOR 36 mth

FOR 36 mth

Fig. 2 Population pyramid
demonstrating frequency and
distribution of FOR values
measured 3 years following shunt
(black) or ETV (gray).
FOR, frontal-occipital horn ratio
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Craniometric data measured during follow-up, excluding cases experiencing treatment failure
Adjusted difference between ETV
and shunt (95% confidence interval)*

Adjusted p value*

26
48.8 (3.7)
81.5 (29.4)

−0.2 (−1.8 to 1.5)
−1.3 (−16.2 to 13.7)

0.86
0.87

2.4 (2.5)
0.54 (0.1)

2.2 (2.5)
0.43 (0.12)

−0.3 (−1.5 to 0.9)
0.09 (0.04 to 0.14)

0.67
0.001

58
50.5 (2.9)
86.1 (25.6)
2.2 (2.0)

24
49.3 (2.7)
73.7 (30.7)
1.4 (1.8)

0.9 (−0.5 to 2.2)
9.4 (−4.5 to 23.4)
0.6 (−0.4 to 1.7)

0.22
0.18
0.21

Metric

ETV

Shunt

12 months
N
HC in cm (mean, SD)
HC %tile (mean, SD)

50
49.4 (3.6)
83.5 (30.3)

HC z-score (mean, SD)
FOR (mean, SD)
18 months
N
HC in cm (mean, SD)
HC %tile (mean, SD)
HC z-score (mean, SD)
2 years
N
HC in cm (mean, SD)
HC %tile (mean, SD)
HC z-score (mean, SD)
3 years
N
HC in cm (mean, SD)
HC %tile (mean, SD)
HC z-score (mean, SD)
FOR (mean, SD)

65
51.5 (3.0)
87.9 (22.9)
2.3 (2.1)

21
49.9 (2.7)
74.3 (33.1)
1.3 (1.8)

1.5 (0.01 to 3.1)
12.6 (−1.4 to 26.5)
1.1 (0.02 to 2.2)

0.048
0.08
0.047

59
51.9 (3.4)
79.4 (31.7)
1.9 (2.6)
0.49 (0.11)

21
50.5 (3.0)
67.8 (34.7)
1.0 (2.1)
0.38 (0.08)

1.2 (−0.4 to 2.9)
9.1 (−7.9 to 26.1)
0.904 (−0.4 to 2.2)
0.11 (0.04 to 0.18)

0.14
0.29
0.16
0.002

5 years
N
HC in cm (mean, SD)
HC %tile (mean, SD)
HC z-score (mean, SD)

43
52.9 (3.3)
75.1 (31.8)
1.6 (2.4)

13
52.0 (2.0)
72.0 (28.9)
0.9 (1.3)

0.6 (−1.4 to 2.6)
0.5 (−20.5 to 21.4)
0.5 (−1.0 to 1.9)

0.56
0.96
0.54

N, cohort size with complete data; ETV, endoscopic third ventriculostomy; HC, head circumference, FOR, frontal-occipital ratio; %tile, percentile
*Adjusted p values and adjusted mean differences were derived from ANCOVA models, adjusted for age, sex, history of infection/hemorrhage, and
geographical continent. P values in italics were deemed statistically significant

paucity of such data in ETV and shunt-treated patients, particularly in the infant population. HC serves as a surrogate clinical marker of brain growth, and infancy is when up to two
thirds of brain growth occurs, highlighting its importance and
those of its derived measures, such as percentile and z-score,
in clinical practice. Nilsson et al. demonstrated the capability
of shunting to decrease HC in an infant cohort (< 12 months)
with a range of underlying pathologies and found that HC
decreased in comparison with a reference population of
healthy children at the ages of 2 and 3 years [16]. Head size
was typically normalized compared with the reference population by 1 year. Although we did not include a control cohort,
we similarly observed an improvement in cranial size metrics
derived from HC measurements over a 5-year period in both
shunt and ETV treated patients. We did find however, that
these values were consistently greater in the ETV group, although the differences were small and non-significant. We

acknowledge that our analyses are post hoc, and the study
was not powered to detect such small differences.
While shunting more reliably decreases ventricular size in
hydrocephalic patients than ETV, we are still trying to understand the neurocognitive implications of ventricular size during childhood development [12]. The primary analysis of the
IIHS suggested long term overall health status and quality of
life for the cohort was, in general, high and that there was no
difference between those treated initially with ETV and shunt
[7]. This is despite ETV patients in general having slightly
larger ventricles by comparison. In a cohort of 93 children
with spina bifida and hydrocephalus, Warf et al. found that
FOR did not significantly differ between patients treated with
VPS, ETV/CPC or managed conservatively, though cognitive
performance was significantly better in those not requiring
treatment, suggesting that ventricle size itself does not consistently correlate with cognitive performance [17]. Kulkarni
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et al. recently corroborated this observation in a randomized
trial that assessed the cognitive outcomes of Ugandan infants
with post-infectious hydrocephalus following treatment with
VPS or ETV/CPC. Brain volumes and cognitive performance
measured at 12 months did not significantly differ between the
treatment groups, even though ventricle size was significantly
greater in the ETV/CPC group suggesting ventricle size is not
the predominant determinant of cognitive function [18]. In the
current study, brain volume was not quantified, although it
may represent a more accurate surrogate marker of cognitive
abilities than ventricular size alone [19], and therefore, its
measurement should be considered in future work.
In this analysis, FOR was found to be significantly larger in
the ETV treated group both at 1 and 3 years of follow-up. This
differs slightly from the IIHS primary outcome analysis, however, where the difference in ventricle size between the ETV
and shunt groups was not significant [7]. This may be explained by the variation in cohort size analyzed; the primary
outcome analysis [7] investigated health status and quality of
life, thus excluding patients with incomplete health outcome
measures at 5 years of follow-up. That cohort was therefore
slightly smaller than the one analyzed herein.
The IIHS has proved valuable in many respects since its
conception [5], continuing to yield data from a relatively
understudied group (infants < 24 months). Other strengths of
the study include its prospective, international, multicenter nature and homogenous patient cohort, based on age and pathology. As such, some valuable insights into differences between
shunting and ETV in infants have been derived [6, 7, 11].
Herein, further insights into how ETV and shunting may affect
cranial growth and ventricle size for infants with aqueductal
stenosis has been provided, which serves to further guide preoperative counseling and post-operative decision making.
This study is limited in several respects. We performed an
intention to treat analysis such that cases were analyzed during
follow-up based on their initial treatment. Almost one third of the
cohort failed treatment (29%) at various stages of follow-up. Of
these, the majority failed ETV treatment and went on to receive a
shunt [11]. As such, crossing-over has served to increase the
heterogeneity of the treatment cohort groups. Excluding cases
failing primary treatment substantially reduced the cohort sizes
for comparisons in the latter years of follow-up; however, the
main observations and differences between treatment groups
were similar (Table 3). The relatively small sample size allows
the possibility that our study was under-powered to demonstrate
significant differences in cranial size metrics. It is possible therefore, that the lack of statistically significant difference in these
comparisons is simply related to lack of power. Furthermore,
potential differences in cranial size metrics in the youngest patients (< 6 months at the time of treatment) may have been
missed as the cohort was not divided based on age. However,
we did adjust for age at treatment in our comparative analyses. In
addition, FOR measurements at 5 years were not available for
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most of the cohort. Nevertheless, it is a reasonable assumption
that most children would have reached a stable ventricle size by
3 years that would be consistent at 5 years of age. Although we
independently adjudicated eligibility criteria for the study, treatment failure was diagnosed by the treating surgeon, thus introducing the possibility of bias. Moreover, as our cohort only included infants with aqueductal stenosis, the findings may not be
applicable to the wider population.

Conclusions
Further analysis of the IIHS cohort of infants treated with ETVor
shunting for aqueductal stenosis and symptomatic triventricular
hydrocephalus has yielded valuable insights into cranial growth
and ventricular size during long-term follow-up. Both ETV and
shunting led to improvements in HC centile, HC z-score, and
FOR measurements during long-term follow-up. Cranial size
did not significantly differ between the treatment groups during
follow-up; however, mean ventricle size was greater in those
undergoing ETV when measured at 1 and 3 years following
initial treatment. Larger studies on broader populations are required to establish the true impact of successful hydrocephalus
treatments on cranial size, ventricular size, brain volume, and
ultimately neurocognitive outcomes.
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